Organization: ExCellThera

Spin-off targets new market for stem cells

A new Montreal biotech company has been launched to commercialize a technology that would overcome the shortage of bone marrow donors for patients with acute myeloid leukemia. Launched by the Institute for Research in Immunology and Cancer – Commercialization of Research and the Centre for Commercialization of Regenerative Medicine, ExCellThera is based on a proprietary…